Recent Publications

Porter CJ and Wilce J.A. (2007) NMR analysis of G7-18NATE, a non-phosphorylated cyclic peptide inhibitor of the Grb7 adapter protein. Biopolymers. 88, 174-81.

J. P. Vivian, C. J. Porter, J. A. Wilce and M. C. J. Wilce (2007) An asymmetric structure of the Bacillus subtilis replication terminator protein in complex with DNA. Journal of Molecular Biology 370, 481-491.

J.W. Schmidberger, J.A. Wilce, J.S.H. Tsang  and Matthew C. J. Wilce (2007) Crystal Structures of the substrate free-enzyme, and reaction intermediate of the HAD Superfamily member, Haloacid Dehalogenase DehIVa from Burkholderia cepacia MBA4 J Mol Biol. 368, 706-717.

Kim HS, Kuwano Y, Zhan M, Pullmann R Jr, Mazan-Mamczarz K, Li H, Kedersha N, Anderson P, Wilce MC, Gorospe M, Wilce JA. (2007) Elucidation of a C-Rich Signature Motif in Target mRNAs of RNA-Binding Protein TIAR. Mol Cell Biol. 27, 6806-6817.

C.J. Porter, J.M. Matthews, J.P. Mackay, S.E. Pursglove, J.W. Schmidberger, P.J. Leedman, S.C. Pero, D.N. Krag, M.C.J. Wilce and J.A. Wilce (2007) Grb7 SH2 domain structure and interactions with a cyclic inhibitor of cancer cell migration and proliferation. BMC Struct Biol. 7:58.

Schmidberger JW, Wilce JA, Weightman AJ, Whisstock JC, Wilce MC. (2008) The crystal structure of DehI reveals a new alpha-haloacid dehalogenase fold and active-site mechanism. J Mol Biol. 378, 284-294.

J. Hodoniczky, C.G. Sims, W.M. Best, J.M.  Bentel and J.A. Wilce (2008) The Intracellular and Nuclear-targeted Delivery of an Anti-androgen Drug by Carrier Peptides. Biopolymers 90,  595-603.

Schmidberger JW, Wilce JA, Weightman AJ, Wilce MC. (2008) Purification, crystallization and preliminary crystallographic analysis of DehI, a group I alpha-haloacid dehalogenase from Pseudomonas putida strain PP3. Acta Crystallogr Sect F Struct Biol Cryst Commun. 64, 596-598.

Bergman, YE., Del Borgo, MP., Gopalan R.D., Jalal, S., Unabia, SE., Ciampini, M., Clayton, DJ., Fletcher, JM, Mulder, RJ., Wilce, JA, Aguilar, MI. and Perlmutter, P (2009) Synthesis of stapled β3-peptides through ring-closing metathesis. (Organic Letters – accepted) (IF 5.128).